SARAH ANN PULLIAM: Open Payments
NPI 1588025761 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 33 payments from 10 companies in 2025. Trend: 2023 $948 · 2024 $361 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $222 |
| Abbott Laboratories | 10 | $207 |
| Corcept Therapeutics | 4 | $199 |
| Novo Nordisk Inc | 5 | $94 |
| Chiesi USA, Inc. | 2 | $49 |
| Sequel Med Tech, LLC | 2 | $48 |
| Insulet Corporation | 2 | $46 |
| ABBVIE INC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Ascensia Diabetes Care Us Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Korlym, MOUNJARO, Ozempic, MYCAPSSA, TWIIST, Omnipod, Rybelsus.
Industry payments across TN — which companies pay providers there.
